Bellevue Group AG
An institutional investment manager in ZURICH. Its Form 13F for the quarter ended Jun 30, 2026, filed Aug 14, 2026. SEC CIK 1674546.
- Reported value$4.75bn
- Positions148
Holdings: 148 positions
The filing on sec.govAs filed, largest first. Reported value is what the manager stated for each position at the quarter end, in US dollars; it is filing data, not a price. Weight is the position's share of the total reported value. Changes compare with the 13F for the quarter ended 2026-03-31. The filing's table has 164 lines; lines for the same security and option type are added together here.
| Issuer | Class | CUSIP | Reported value$m | Weight | Shares | Put or call | Change on the quarter before |
|---|---|---|---|---|---|---|---|
| Amgen IncAMGN | COM | 031162100 | 308 | 6.5% | 851,550 | Added+556,192 | |
| Vertex Pharmaceuticals IncVRTX | COM | 92532F100 | 287 | 6.0% | 578,634 | Reduced−103,274 | |
| Argenx SEARGX | SPONSORED ADR | 04016X101 | 279 | 5.9% | 301,000 | Reduced−12,000 | |
| Gilead Sciences IncGILD | COM | 375558103 | 273 | 5.7% | 2,158,772 | Added+988,893 | |
| Revolution Medicines IncRVMD | COM | 76155X100 | 196 | 4.1% | 1,048,014 | Reduced−496,442 | |
| Oruka Therapeutics IncORKA | COM | 687604108 | 158 | 3.3% | 1,657,190 | Added+1,150,182 | |
| Insmed IncINSM | COM PAR $.01 | 457669307 | 149 | 3.1% | 1,393,418 | Added+1,383,384 | |
| Scholar Rock HLDG CorpSRRK | COM | 80706P103 | 135 | 2.8% | 2,449,547 | Reduced−1,135,026 | |
| Nuvalent Inc | COM | 670703107 | 130 | 2.7% | 1,053,268 | Unchanged | |
| Viridian Therapeutics IncVRDN | COM | 92790C104 | 124 | 2.6% | 6,731,909 | Added+5,765 | |
| Relay Therapeutics IncRLAY | COM | 75943R102 | 116 | 2.4% | 6,185,970 | Reduced−1,609,272 | |
| Vaxcyte IncPCVX | COM | 92243G108 | 115 | 2.4% | 1,971,935 | Added+781,238 | |
| United Therapeutics Corp DelUTHR | COM | 91307C102 | 102 | 2.1% | 188,515 | Added+186,438 | |
| Intuitive Surgical IncISRG | COM NEW | 46120E602 | 101 | 2.1% | 254,809 | Reduced−31,845 | |
| Regeneron PharmaceuticalsREGN | COM | 75886F107 | 98.1 | 2.1% | 157,291 | Reduced−121,383 | |
| Crinetics Pharmaceuticals in | COM | 22663K107 | 98.0 | 2.1% | 2,620,000 | Reduced−660,000 | |
| Bridgebio Pharma IncBBIO | COM | 10806X102 | 88.6 | 1.9% | 1,189,506 | Added+1,164,129 | |
| Immunocore Holdings plcIMCR | ADS | 45258D105 | 88.5 | 1.9% | 2,788,245 | Reduced−8,558 | |
| Abbott LaboratoriesABT | COM | 002824100 | 85.9 | 1.8% | 947,115 | Reduced−204,520 | |
| Stryker CorporationSYK | COM | 863667101 | 84.5 | 1.8% | 268,461 | Added+51,224 | |
| Medtronic plc | SHS | G5960L103 | 77.8 | 1.6% | 994,233 | Added+36,904 | |
| Ionis Pharmaceuticals IncIONS | COM | 462222100 | 77.1 | 1.6% | 972,258 | Reduced−846,407 | |
| Enliven Therapeutics IncELVN | COM | 29337E102 | 75.6 | 1.6% | 1,490,000 | Reduced−830,867 | |
| Vera Therapeutics IncVERA | CL A | 92337R101 | 73.4 | 1.5% | 1,710,808 | Added+37 | |
| Jade Biosciences IncJBIO | COM NEW | 008064206 | 67.9 | 1.4% | 3,057,996 | Reduced−443,506 | |
| Edwards Lifesciences CorpEW | COM | 28176E108 | 66.9 | 1.4% | 739,234 | Reduced−100,217 | |
| Ultragenyx Pharmaceutical inRARE | COM | 90400D108 | 66.2 | 1.4% | 1,982,775 | Reduced−397,225 | |
| Unitedhealth Group IncUNH | COM | 91324P102 | 62.0 | 1.3% | 149,127 | Added+924 | |
| Dexcom IncDXCM | COM | 252131107 | 55.4 | 1.2% | 822,489 | Added+33,723 | |
| Celldex Therapeutics Inc NewCLDX | COM NEW | 15117B202 | 44.7 | 0.9% | 1,200,000 | Unchanged | |
| Avalyn Pharmaceuticals IncAVLN | COM SHS | 05348Y105 | 44.4 | 0.9% | 1,350,000 | New+1,350,000 | |
| Damora Therapeutics Inc | COM NEW | 36322Q206 | 42.1 | 0.9% | 1,618,846 | Reduced−679,154 | |
| Disc Medicine IncIRON | COM | 254604101 | 41.0 | 0.9% | 560,000 | Added+100,686 | |
| Thermo Fisher Scientific IncTMO | COM | 883556102 | 40.0 | 0.8% | 79,816 | Added+15,404 | |
| Boston Scientific CorpBSX | COM | 101137107 | 37.9 | 0.8% | 887,650 | Reduced−579,244 | |
| ELI Lilly & CoLLY | COM | 532457108 | 35.8 | 0.8% | 29,882 | Reduced−4,050 | |
| CG Oncology IncCGON | COM | 156944100 | 35.1 | 0.7% | 493,596 | New+493,596 | |
| Idexx Labs IncIDXX | COM | 45168D104 | 32.5 | 0.7% | 61,780 | Reduced−27,351 | |
| Resmed IncRMD | COM | 761152107 | 28.9 | 0.6% | 148,195 | Reduced−11,151 | |
| Krystal Biotech IncKRYS | COM | 501147102 | 28.8 | 0.6% | 77,530 | Reduced−404,255 | |
| Monte Rosa Therapeutics IncGLUE | COM | 61225M102 | 28.8 | 0.6% | 1,190,000 | Reduced−60,000 | |
| Danaher Corp DelDHR | COM | 235851102 | 27.4 | 0.6% | 143,844 | Reduced−58,320 | |
| Johnson & JohnsonJNJ | COM | 478160104 | 26.2 | 0.6% | 103,280 | Reduced−15,822 | |
| Seaport Therapeutics IncSPTX | COMMON STOCK | 81221K108 | 23.9 | 0.5% | 1,100,000 | New+1,100,000 | |
| Palvella Therapeutics Inc NePVLA | COM | 697947109 | 23.7 | 0.5% | 155,000 | New+155,000 | |
| Align Technology IncALGN | COM | 016255101 | 23.6 | 0.5% | 139,680 | Unchanged | |
| Annexon IncANNX | COM | 03589W102 | 23.4 | 0.5% | 4,100,016 | Reduced−1,057,274 | |
| Humana IncHUM | COM | 444859102 | 23.2 | 0.5% | 58,398 | Reduced−6,100 | |
| Elevance Health Inc FormerlyELV | COM | 036752103 | 21.8 | 0.5% | 56,449 | Added+3,931 | |
| Tango Therapeutics IncTNGX | COM | 87583X109 | 21.7 | 0.5% | 694,182 | Reduced−1,705,818 | |
| Steris plc | SHS USD | G8473T100 | 21.0 | 0.4% | 99,877 | Reduced−1 | |
| Spyre Therapeutics IncSYRE | COM NEW | 00773J202 | 20.4 | 0.4% | 229,931 | New+229,931 | |
| Hemab Therapeutics Holdings IncCOAG | COM SHS | 423494103 | 20.2 | 0.4% | 550,000 | New+550,000 | |
| Insulet CorpPODD | COM | 45784P101 | 19.4 | 0.4% | 127,498 | Reduced−36,158 | |
| The Cigna GroupCI | COM | 125523100 | 18.3 | 0.4% | 66,500 | Reduced−31,763 | |
| Glaukos CorpGKOS | COM | 377322102 | 18.0 | 0.4% | 128,667 | Reduced−17,036 | |
| CVS Health CorpCVS | COM | 126650100 | 17.5 | 0.4% | 169,366 | Added+80,003 | |
| Becton Dickinson & CoBDX | COM | 075887109 | 16.6 | 0.3% | 109,729 | Reduced−12,158 | |
| GE Healthcare Technologies IGEHC | COMMON STOCK | 36266G107 | 16.2 | 0.3% | 252,744 | Reduced−164,143 | |
| Livanova plc | SHS | G5509L101 | 16.1 | 0.3% | 195,621 | Added+9,436 | |
| Centene Corp DelCNC | COM | 15135B101 | 14.7 | 0.3% | 228,865 | Reduced−32,201 | |
| Merck & Co IncMRK | COM | 58933Y105 | 14.5 | 0.3% | 113,061 | Reduced−93,530 | |
| Cooper Cos IncCOO | COM | 216648501 | 14.1 | 0.3% | 197,135 | Reduced−75,049 | |
| Parabilis Medicines IncPBLS | COM | 698955101 | 13.7 | 0.3% | 500,000 | New+500,000 | |
| Teva Pharmaceutical Inds Ltd | SPONSORED ADS | 881624209 | 11.7 | 0.2% | 345,899 | Added+95,817 | |
| Globus Med IncGMED | CL A | 379577208 | 11.5 | 0.2% | 146,108 | Reduced−101,153 | |
| Procept Biorobotics CorpPRCT | COM | 74276L105 | 11.3 | 0.2% | 502,286 | Unchanged | |
| Zimmer Biomet Holdings IncZBH | COM | 98956P102 | 10.9 | 0.2% | 126,707 | Reduced−28,864 | |
| Veeva Sys IncVEEV | CL A COM | 922475108 | 10.5 | 0.2% | 59,347 | Added+2,830 | |
| Abbvie IncABBV | COM | 00287Y109 | 10.2 | 0.2% | 40,476 | Reduced−53,091 | |
| 10X Genomics IncTXG | CL A COM | 88025U109 | 10.0 | 0.2% | 261,470 | Reduced−68,022 | |
| HCA Healthcare IncHCA | COM | 40412C101 | 9.3 | 0.2% | 23,750 | Reduced−14,015 | |
| Aura Biosciences IncAURA | COM | 05153U107 | 8.3 | 0.2% | 1,166,667 | New+1,166,667 | |
| McKesson CorpMCK | COM | 58155Q103 | 7.3 | 0.2% | 9,625 | Reduced−12,727 | |
| Tenet Healthcare CorpTHC | COM NEW | 88033G407 | 7.3 | 0.2% | 38,868 | Added+599 | |
| Protagonist Therapeutics IncPTGX | COM | 74366E102 | 6.8 | 0.1% | 55,682 | Added+41,235 | |
| Natera IncNTRA | COM | 632307104 | 6.7 | 0.1% | 24,806 | Reduced−6,888 | |
| Transmedics Group IncTMDX | COM | 89377M109 | 6.7 | 0.1% | 101,139 | Unchanged | |
| Molina Healthcare IncMOH | COM | 60855R100 | 6.3 | 0.1% | 27,761 | New+27,761 | |
| Alkermes plc | SHS | G01767105 | 6.3 | 0.1% | 120,243 | Added+111,373 | |
| Royalty Pharma plc | SHS CLASS A | G7709Q104 | 6.3 | 0.1% | 112,311 | Added+74,015 | |
| Waystar HLDG CorpWAY | COM | 946784105 | 6.0 | 0.1% | 293,592 | Added+37,453 | |
| Privia Health Group IncPRVA | COM | 74276R102 | 5.8 | 0.1% | 226,703 | Unchanged | |
| GMR Solutions IncGMRS | COM CL A | 38013D106 | 5.2 | 0.1% | 333,333 | New+333,333 | |
| Neurocrine Biosciences IncNBIX | COM | 64125C109 | 4.1 | <0.1% | 24,037 | Added+19,391 | |
| Omada Health IncOMDA | COM | 68170A108 | 3.5 | <0.1% | 157,938 | Unchanged | |
| Kestra Med Technologies Ltd | SHS | G52441105 | 3.3 | <0.1% | 129,215 | Added+13,625 | |
| Medline IncMDLN | COM CL A | 58507V107 | 3.2 | <0.1% | 82,153 | Reduced−54,482 | |
| Illumina IncILMN | COM | 452327109 | 3.2 | <0.1% | 18,134 | Reduced−2,089 | |
| Beone Medicines LtdONC | SPONSORED ADS | 07725L102 | 3.0 | <0.1% | 10,474 | Added+6,662 | |
| Newamsterdam Pharma Company | ORDINARY SHARES | N62509109 | 2.9 | <0.1% | 86,994 | Added+59,333 | |
| Madrigal Pharmaceuticals IncMDGL | COM | 558868105 | 2.5 | <0.1% | 4,675 | Added+1,635 | |
| State STR SPDR S&P 500 ETF TSPY | TR UNIT | 78462F103 | 2.0 | <0.1% | 2,700 | Unchanged | |
| Biontech SEBNTX | SPONSORED ADS | 09075V102 | 2.0 | <0.1% | 21,229 | Added+378 | |
| Adaptive Biotechnologies CorADPT | COM | 00650F109 | 1.9 | <0.1% | 89,439 | Added+13,258 | |
| Cytokinetics IncCYTK | COM NEW | 23282W605 | 1.6 | <0.1% | 19,007 | Added+10,166 | |
| Alamar Biosciences IncALMR | COMMON STOCK | 010911105 | 1.5 | <0.1% | 55,738 | New+55,738 | |
| Phreesia IncPHR | COM | 71944F106 | 1.4 | <0.1% | 140,495 | Added+9,503 | |
| Mobia Med IncMOBI | COMMON STOCK | 60705V103 | 1.3 | <0.1% | 100,000 | New+100,000 | |
| Billiontoone IncBLLN | CL A | 090168105 | 1.3 | <0.1% | 10,554 | Unchanged | |
| Beta Bionics IncBBNX | COM | 08659B102 | 1.1 | <0.1% | 72,152 | Unchanged | |
| Legend Biotech CorpLEGN | SPONSORED ADS | 52490G102 | 1.0 | <0.1% | 33,054 | Reduced−2,832 | |
| Pfizer IncPFE | COM | 717081103 | 0.9 | <0.1% | 38,431 | Reduced−69,204 | |
| Abivax SAABVX | SPONSORED ADS | 00370M103 | 0.9 | <0.1% | 6,397 | Added+5,349 | |
| Encompass Health CorpEHC | COM | 29261A100 | 0.7 | <0.1% | 6,951 | Reduced−2,878 | |
| Axsome Therapeutics Inc.AXSM | COM | 05464T104 | 0.7 | <0.1% | 2,689 | Reduced−492 | |
| Certara IncCERT | COM | 15687V109 | 0.7 | <0.1% | 99,442 | Unchanged | |
| Agomab Therapeutics NVAGMB | SPONSORED ADS | 00860C102 | 0.6 | <0.1% | 49,248 | Reduced−752 | |
| Praxis Precision Medicines IPRAX | COM NEW | 74006W207 | 0.6 | <0.1% | 1,847 | Added+90 | |
| Apple IncAAPL | COM | 037833100 | 0.5 | <0.1% | 1,768 | Reduced−1,552 | |
| Garmin Ltd | SHS | H2906T109 | 0.5 | <0.1% | 1,976 | Added+655 | |
| Denali Therapeutics IncDNLI | COM | 24823R105 | 0.5 | <0.1% | 17,766 | Unchanged | |
| Vaneck ETF Trust | GOLD MINERS ETF | 92189F106 | 0.4 | <0.1% | 5,750 | Unchanged | |
| Veradermics IncMANE | COMMON STOCK | 922967104 | 0.4 | <0.1% | 3,468 | New+3,468 | |
| Alphabet IncGOOGL | CAP STK CL A | 02079K305 | 0.4 | <0.1% | 907 | Added+593 | |
| Definium Therapeutics IncDFTX | COM SHS | 24477V105 | 0.4 | <0.1% | 8,391 | New+8,391 | |
| Travere Therapeutics IncTVTX | COM | 89422G107 | 0.4 | <0.1% | 6,908 | Reduced−1,991 | |
| Amazon Com IncAMZN | COM | 023135106 | 0.4 | <0.1% | 1,605 | Added+252 | |
| Halozyme Therapeutics IncHALO | COM | 40637H109 | 0.3 | <0.1% | 4,348 | Added+491 | |
| Alnylam Pharmaceuticals IncALNY | COM | 02043Q107 | 0.3 | <0.1% | 1,092 | Reduced−233,451 | |
| Crispr Therapeutics AG | NAMEN AKT | H17182108 | 0.3 | <0.1% | 5,818 | Added+802 | |
| Structure Therapeutics IncGPCR | SPONSORED ADS | 86366E106 | 0.3 | <0.1% | 4,762 | Reduced−2,041 | |
| Viatris IncVTRS | COM | 92556V106 | 0.3 | <0.1% | 15,778 | New+15,778 | |
| Mineralys Therapeutics IncMLYS | COM | 603170101 | 0.2 | <0.1% | 8,753 | Reduced−20,621 | |
| Summit Therapeutics IncSMMT | COM | 86627T108 | 0.2 | <0.1% | 15,279 | Reduced−579 | |
| Cardinal Health IncCAH | COM | 14149Y108 | 0.2 | <0.1% | 852 | Reduced−11 | |
| Cogent Biosciences IncCOGT | COM | 19240Q201 | 0.2 | <0.1% | 4,870 | New+4,870 | |
| Tempus Ai IncTEM | CL A | 88023B103 | 0.2 | <0.1% | 3,213 | Reduced−1,737 | |
| Cencora IncCOR | COM | 03073E105 | 0.2 | <0.1% | 576 | Reduced−1,140 | |
| PTC Therapeutics IncPTCT | COM | 69366J200 | 0.1 | <0.1% | 1,626 | Reduced−309 | |
| Caris Life Sciences IncCAI | COM | 142152107 | 0.1 | <0.1% | 6,418 | Unchanged | |
| Rhythm Pharmaceuticals IncRYTM | COM | 76243J105 | 0.1 | <0.1% | 1,016 | Unchanged | |
| Arrowhead Pharmaceuticals inARWR | COM | 04280A100 | 0.1 | <0.1% | 1,191 | Reduced−354 | |
| Nvidia CorporationNVDA | COM | 67066G104 | 0.1 | <0.1% | 408 | Unchanged | |
| Labcorp Holdings IncLH | COM SHS | 504922105 | 0.1 | <0.1% | 280 | Unchanged | |
| Biogen IncBIIB | COM | 09062X103 | 0.1 | <0.1% | 338 | Reduced−3,315 | |
| Bristol-Myers Squibb CoBMY | COM | 110122108 | 0.1 | <0.1% | 1,216 | Reduced−15,822 | |
| Waters CorpWAT | COM | 941848103 | 0.1 | <0.1% | 179 | New+179 | |
| Microsoft CorpMSFT | COM | 594918104 | 0.1 | <0.1% | 172 | Unchanged | |
| Iqvia Holdings IncIQV | COM | 46266C105 | 0.1 | <0.1% | 293 | Reduced−447 | |
| Incyte CorpINCY | COM | 45337C102 | 0.1 | <0.1% | 486 | Unchanged | |
| Mettler Toledo InternationalMTD | COM | 592688105 | 0.0 | <0.1% | 36 | Unchanged | |
| Agilent Technologies IncA | COM | 00846U101 | 0.0 | <0.1% | 330 | Reduced−334 | |
| Qualcomm IncQCOM | COM | 747525103 | 0.0 | <0.1% | 197 | Unchanged | |
| Zoetis IncZTS | CL A | 98978V103 | 0.0 | <0.1% | 390 | Reduced−143 | |
| Oracle CorpORCL | COM | 68389X105 | 0.0 | <0.1% | 191 | Unchanged | |
| Quest Diagnostics IncDGX | COM | 74834L100 | 0.0 | <0.1% | 131 | Unchanged | |
| Recursion Pharmaceuticals inRXRX | CL A | 75629V104 | 0.0 | <0.1% | 4,627 | Unchanged |
Sold out: 24 positions
Held at the end of the quarter before and not reported this quarter.
| Issuer | Class | CUSIP | Reported value$ | Weight | Shares | Put or call | Change on the quarter before |
|---|---|---|---|---|---|---|---|
| Accenture plc Ireland | SHS CLASS A | G1151C101 | 0.0 | 0.0% | 0 | Sold out−1,500 | |
| Adobe IncADBE | COM | 00724F101 | 0.0 | 0.0% | 0 | Sold out−1,200 | |
| Alibaba Group HLDG LtdBABA | SPONSORED ADS | 01609W102 | 0.0 | 0.0% | 0 | Sold out−4,700 | |
| Ascendis Pharma A/S | SPONSORED ADR | 04351P101 | 0.0 | 0.0% | 0 | Sold out−536 | |
| Atrium Therapeutics IncRNA | COM | 04965N104 | 0.0 | 0.0% | 0 | Sold out−263,096 | |
| Blackrock IncBLK | COM | 09290D101 | 0.0 | 0.0% | 0 | Sold out−450 | |
| BP plcBP | SPONSORED ADR | 055622104 | 0.0 | 0.0% | 0 | Sold out−15,644 | |
| Bridgebio Oncology TherapeutBBOT | COM NEW | 107924102 | 0.0 | 0.0% | 0 | Sold out−6,982 | |
| Centessa Pharmaceuticals plc | SPONSORED ADS | 152309100 | 0.0 | 0.0% | 0 | Sold out−9,030 | |
| Cisco Sys IncCSCO | COM | 17275R102 | 0.0 | 0.0% | 0 | Sold out−8,000 | |
| Edgewise Therapeutics IncEWTX | COM | 28036F105 | 0.0 | 0.0% | 0 | Sold out−1,528,518 | |
| Equinor ASAEQNR | SPONSORED ADR | 29446M102 | 0.0 | 0.0% | 0 | Sold out−17,573 | |
| Exxon Mobil Corp | COM | 30231G102 | 0.0 | 0.0% | 0 | Sold out−4,370 | |
| Inspire Med Sys IncINSP | COM | 457730109 | 0.0 | 0.0% | 0 | Sold out−99,735 | |
| Jd.Com IncJD | SPON ADS CL A | 47215P106 | 0.0 | 0.0% | 0 | Sold out−11,000 | |
| Masimo Corp | COM | 574795100 | 0.0 | 0.0% | 0 | Sold out−8,753 | |
| Mastercard IncorporatedMA | CL A | 57636Q104 | 0.0 | 0.0% | 0 | Sold out−1,100 | |
| Olema Pharmaceuticals IncOLMA | COM | 68062P106 | 0.0 | 0.0% | 0 | Sold out−16,443 | |
| Penumbra IncPEN | COM | 70975L107 | 0.0 | 0.0% | 0 | Sold out−12,267 | |
| Procter & Gamble CoPG | COM | 742718109 | 0.0 | 0.0% | 0 | Sold out−3,900 | |
| Qiagen NV | ORD SHARES | N72482156 | 0.0 | 0.0% | 0 | Sold out−243 | |
| Shell plcSHEL | SPON ADS | 780259305 | 0.0 | 0.0% | 0 | Sold out−7,844 | |
| Visa IncV | COM CL A | 92826C839 | 0.0 | 0.0% | 0 | Sold out−1,400 | |
| Wave Life Sciences Ltd | SHS | Y95308105 | 0.0 | 0.0% | 0 | Sold out−5,261 |
Source: SEC EDGAR, Form 13F-HR, accession 0001104659-26-096739 (on sec.gov). Last ingested by Listed: Oct 22, 2026, 05:26 ET. Listed shows no prices and gives no investment advice.